Coglavax

Product description

COMPOSITION: – Cl. perfringens type A, C and D: Alpha toxoid 2 IU/mℓ Beta toxoid 10 IU/mℓ Epsilon toxoid 5 IU/mℓ – Cl. septicum toxoid 2,5 IU/mℓ – Cl. novyi type B toxoid 3,5 IU/mℓ – Cl. tetani toxoid 2,5 IU/mℓ – Cl. chauvoei 100 % protection – Adjuvant aluminium hydroxide.

WARNINGS: Vaccinate healthy animals only. The vaccine contains an adjuvant that may result in a mild, temporary local reaction at the site of injection. A small number of individuals may fail to develop an immune response in any group of animals as a result of immuno-incompetence or for other reasons. As with most inactivated vaccines, significant development of immunity cannot be expected until two weeks after the second dose of the vaccination course. During the vaccination process, stressing of the animals should be avoided, particularly during the later stages of pregnancy when there is an increased risk of induction of abortion and metabolic disease conditions. Occasional hypersensitivity reactions may occur. Keep out of reach of children, uninformed persons and animals. Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

PRECAUTIONS: Observe the usual aseptic precautions in the administration of this vaccine. Do not mix with any other vaccine. In case of accidental self-injection to the user, immediately consult a doctor. Destroy any partially used packs by for example burning; dispose of all the vaccine containers when the vaccination is completed. It is good vaccination practice not to allow vaccines to come into contact with human eyes or mucous membranes. Wash and disinfect your hands with a disinfectant after vaccination.

DIRECTIONS FOR USE: Use only as directed. Shake well before use. After the first opening of the container, it is recommended to use the vaccine within 8 hours. The administration is by subcutaneous injection in the loose skin on the upper side of the neck. No alcohol or any other disinfectants should be used for sterilisation of the needles and syringes.

DOSAGE:

• Sheep and calves weighing less than 100 kg: 2 mℓ
• Calves and adult cattle: 4 mℓ

EFFICACY: Cattle and Sheep: For the active immunisation of cattle and sheep against infections caused by Cl. perfringens A, C and D, Cl. novyi B, Cl. septicum, Cl. tetani and Cl. chauvoei in the following bacterial disease conditions: Pulpy Kidney Disease in sheep Black Quarter in cattle and sheep Gas Gangrene in cattle and sheep Tetanus in cattle and sheep Malignant Oedema in cattle and sheep Enterotoxaemia (bloodgut) in adult sheep and lambs.

STORAGE: Store between 2 – 8 degrees Celcius. Protect from light. Do not freeze.

IDENTIFICATION: Clear brown vaccine suspension.

Please note, we offer payment terms for approved businesses. To apply, please complete and submit the application form.